This episode of Pharma Fundamentals provides an introduction to hold times in biopharmaceutical manufacturing and how they differ from hold times in small-molecule drug manufacturing.
Robert Dream
Advertisement
Robert Dream is managing director of HDR Company and a member of PharmTech’s Editorial Advisory Board.
Articles by Robert Dream
This episode of Pharma Fundamentals provides an introduction to hold times in biopharmaceutical manufacturing and how they differ from hold times in small-molecule drug manufacturing.
The scientific basis, regulatory expectations, validation approaches of hold times in biopharmaceuticals are presented along with real-world examples.
Advertisement
Latest Updated Articles
Pharma Fundamentals: Hold Times in BiopharmaceuticalsJune 23rd 2026
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
H1 2026 in Review: AI Adoption, Onshoring, and Data Gaps
2
What the OSTP’s New Policy Blueprint Means for Pharma Manufacturing and Development
3
Is Organizational Readiness Pharma's Real AI Barrier in 2026?
4
Regulatory Roundup—July 2026
5